COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway
Ümit Haluk Yeşilkaya, Meltem Sen, Yasin Hasan Balcıoğlu
Topics & Concepts
GlutamatergicGlutamate receptorGlutamineMedicineCognitionNeuroscienceCoronavirus disease 2019 (COVID-19)NeuroimagingCognitive impairmentAudiologyInternal medicinePsychiatryPsychologyDiseaseBiologyAmino acidBiochemistryReceptorInfectious disease (medical specialty)Long-Term Effects of COVID-19Functional Brain Connectivity StudiesEpilepsy research and treatment